Compile Data Set for Download or QSAR
Report error Found 24 Enz. Inhib. hit(s) with all data for entry = 50011586
TargetUrokinase-type plasminogen activator(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108364(N-(5-Bromo-3-chloro-pyridin-2-yl)-guanidine | CHEM...)
Affinity DataKi:  2.90E+3nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108362(N-(5-Bromo-pyridin-2-yl)-guanidine | CHEMBL54357)
Affinity DataKi:  3.13E+3nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108360(N-(3-Bromo-5-chloro-pyridin-2-yl)-guanidine | CHEM...)
Affinity DataKi:  4.83E+3nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108354(N-(3,5-Dichloro-pyridin-2-yl)-guanidine | CHEMBL29...)
Affinity DataKi:  5.47E+3nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50053590(N-(4-Chloro-phenyl)-guanidine | N-(4-chlorophenyl)...)
Affinity DataKi:  6.70E+3nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108355(N-(4-Phenyl-pyridin-2-yl)-guanidine | CHEMBL54467)
Affinity DataKi:  7.10E+3nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108352(N-(3,5-Dichloro-4-methyl-pyridin-2-yl)-guanidine |...)
Affinity DataKi:  8.70E+3nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108363(N-(5-Chloro-pyridin-2-yl)-guanidine | CHEMBL298989)
Affinity DataKi:  1.00E+4nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasminogen(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108353(N-Pyridin-4-yl-guanidine | CHEMBL298550)
Affinity DataKi:  1.69E+4nMAssay Description:Ability to inhibit human tissue plasminogen activator stimulatorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50053618(N-Pyridin-2-yl-guanidine | CHEMBL128047)
Affinity DataKi:  2.95E+4nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108365(N-(5-Methyl-pyridin-2-yl)-guanidine | CHEMBL53031)
Affinity DataKi:  3.23E+4nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108358(N-(3-Methyl-pyridin-2-yl)-guanidine | CHEMBL52361)
Affinity DataKi:  3.77E+4nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108361(N-(3-Chloro-5-trifluoromethyl-pyridin-2-yl)-guanid...)
Affinity DataKi:  4.07E+4nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasminogen(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50053590(N-(4-Chloro-phenyl)-guanidine | N-(4-chlorophenyl)...)
Affinity DataKi: <5.00E+4nMAssay Description:Ability to inhibit human plasmin using Chromozym-PL as substrateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108367(N-(4-Methoxy-pyridin-2-yl)-guanidine | CHEMBL55184)
Affinity DataKi:  5.33E+4nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108359(N-(3-Methoxy-pyridin-2-yl)-guanidine | CHEMBL30013...)
Affinity DataKi:  6.20E+4nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108366(N-(4-Methyl-pyridin-2-yl)-guanidine | CHEMBL54640)
Affinity DataKi:  8.38E+4nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108356(N-(3-Hydroxy-pyridin-2-yl)-guanidine | CHEMBL55051)
Affinity DataKi:  1.47E+5nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108357(N-(6-Methyl-pyridin-2-yl)-guanidine | CHEMBL54545)
Affinity DataKi:  1.73E+5nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasminogen(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108352(N-(3,5-Dichloro-4-methyl-pyridin-2-yl)-guanidine |...)
Affinity DataKi:  1.77E+5nMAssay Description:Ability to inhibit human tissue plasminogen activator stimulatorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasminogen(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108359(N-(3-Methoxy-pyridin-2-yl)-guanidine | CHEMBL30013...)
Affinity DataKi: <2.33E+5nMAssay Description:Ability to inhibit human plasmin using Chromozym-PL as substrateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasminogen(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108365(N-(5-Methyl-pyridin-2-yl)-guanidine | CHEMBL53031)
Affinity DataKi:  2.45E+5nMAssay Description:Ability to inhibit human tissue plasminogen activator stimulatorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetTissue-type plasminogen activator(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108360(N-(3-Bromo-5-chloro-pyridin-2-yl)-guanidine | CHEM...)
Affinity DataKi:  2.72E+5nMAssay Description:Ability to inhibit human tissue plasminogen activator stimulatorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108368(N-Pyrimidin-2-yl-guanidine | CHEMBL54989)
Affinity DataKi:  2.92E+5nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed